Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Assay and Drug Development Technologies|April 20, 2004
Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptorsJayne Chin, Alan D Adams, Aileen Bouffard, et al.
Analytical Biochemistry|June 27, 2006
A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activationShane Marine, Elize Zamiara, S Todd Smith, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology|November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Assay and Drug Development Technologies|June 29, 2010
A 1,536-well ultra-high-throughput siRNA screen to identify regulators of the Wnt/beta-catenin pathwayNamjin Chung, Shane Marine, Emily A Smith, et al.
Pilot and Feasibility Studies|October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Vaccine: X|May 3, 2021
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike proteinJillian M DiMuzio, Baron C Heimbach, Raymond J Howanski, et al.
Blood|January 9, 2007
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levelsKevin R Viel, Deepa K Machiah, Diane M Warren, et al.
Trials|August 24, 2024
LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorderDimitri Daldegan-Bueno, Carina Joy Donegan, Anna Forsyth, et al.
Molecular and Cellular Biology|September 27, 2006
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptionsSteven R Bartz, Zhan Zhang, Julja Burchard, et al.
Pageof 6